A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity ‐score weighted multicenter approach
Source: American Journal of Hematology - Category: Hematology Authors: Francesco Lanza, Francesco Saraceni, Annalisa Pezzi, Massimo Martino, Alberto Bosi, Nicola Cascavilla, Pellegrino Musto, Eliana Zuffa, Monica Tani, Claudia Cellini, Daniele Laszlo, Francesca Bonifazi, Tags: CORRESPONDENCE Source Type: research
More News: Filgrastim | Hematology | Lymphoma | Myeloma | Neulasta | Neupogen | Stem Cell Therapy | Stem Cells